TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive A Special Report: Language With A Purpose–von Eschenbach’s Four Years at NCI. May 19, 2006